216 related articles for article (PubMed ID: 10561455)
1. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
[TBL] [Abstract][Full Text] [Related]
2. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
5. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
[TBL] [Abstract][Full Text] [Related]
6. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
8. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
10. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
[TBL] [Abstract][Full Text] [Related]
11. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
[TBL] [Abstract][Full Text] [Related]
12. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
13. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
15. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
16. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
17. Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.
Fukuta K; Yokomatsu T; Abe R; Asanagi M; Makino T
Glycoconj J; 2000 Dec; 17(12):895-904. PubMed ID: 11511814
[TBL] [Abstract][Full Text] [Related]
18. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
[TBL] [Abstract][Full Text] [Related]
20. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
Müller S; Hanisch FG
J Biol Chem; 2002 Jul; 277(29):26103-12. PubMed ID: 12000758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
